You are here

  • Home
  • Archive
  • Volume 69, Issue 10
  • Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma

Article Text

Article menu
Download PDFPDF
PostScript
PostScript
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma

https://doi.org/10.1136/gutjnl-2019-320116

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors ZF contributed to the study concept and design. ZF and PR acquired, analysed and interpreted the data. ZF performed the statistical analysis and drafted the manuscript. ZF, RP and WW made critical revisions to the manuscript. PR and WW supervised the study.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.